Medical devices, healthcare technology and the business of care
510(k) clearance · K262257

Spine Planning (3.0); Spine & Trauma Navigation; Alignment System Spine

Brainlab SE · Decision date Sep 30, 2026

MEDTECHLEDGER EXPLANATIONK262257

What did the FDA decide?

FDA recorded a substantially equivalent decision for K262257 on 2026-09-30, covering Spine Planning (3.0), Spine & Trauma Navigation and Alignment System Spine, submitted by Brainlab SE of Munich, Germany. The filing is a traditional 510(k) under regulation 882.4560, device classification Orthopedic Stereotaxic Instrument, product code OLO, with Neurology as the regulation medical specialty and the Orthopedic panel as reviewer. The decision is a clearance, not a PMA approval.

The reviewed documents describe Spine Planning software for pre-operative or intra-operative spinal surgery planning, displaying 2D X-ray and 3D images, with vertebrae labeling and measurement on 2D images and vertebra detection on Digitally Reconstructed Radiograph images of 3D datasets for atlas registration. The documents also describe screw and interbody device planning and navigation with surgical instruments. The source does not state which elements are new relative to prior clearances, and no summary statement text is present in the supplied data.

The record lists a 07/02/2026 receipt date and a page update of 11/02/2026. The supplied excerpts truncate the indication statement, so the full labeled indications, patient-selection criteria and any clinical performance data remain unknown from this material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Sep 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262257
Regulatory pathway
510(k) premarket notification
Applicant
Brainlab SE
Product code
OLO
Decision code
SESE
Decision date
Sep 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthopedic Stereotaxic Instrument.

Applicant
Brainlab SE
Product code
OLO
FDA device class
2

FDA decision timeline

  1. K262257 received

    Application receipt date recorded by FDA.

  2. K262257 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OLO

Product / regulatory recordCompanyPathwayDecision dateSource
GPS AnkleK262567
Blue Ortho510(k) clearanceOct 26, 2026FDA
7D Surgical ULC510(k) clearanceOct 19, 2026FDA
THINK Surgical, Inc.510(k) clearanceOct 16, 2026FDA
CarboFix Orhtopedics , Ltd.510(k) clearanceOct 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Brainlab SE

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Munich

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records